Back to top

Image: Bigstock

4 Stocks With Solid Earnings Acceleration to Watch

Read MoreHide Full Article
Earnings are essentially revenues that the company generates after deducting the cost of production over a given period of time. And this metric is one of the most important variables in influencing the share price of a company. However, earnings acceleration works even better when it comes to lifting the stock price. Several studies have shown that a majority of successful stocks had seen acceleration in earnings before an uptick in the stock price.
 
Earnings acceleration, in fact, is the incremental growth in a company’s earnings per share (EPS). In other words, if the rate of a company’s quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.
 
In case of earnings growth, you pay for something that is already reflected in the stock price. But earnings acceleration helps spot stocks that haven’t caught the attention of investors yet, which once secured will invariably lead to a rally in the share price. This is because earnings acceleration considers both direction and magnitude of growth rates.
 
Increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period of time. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may at times drag prices down.
 
Hence, earnings acceleration should be viewed as a key metric for share price outperformance.
 
The Winning Strategy
 
Let’s look at stocks for which the last two quarter-over-quarter percentage EPS growth rates exceed the growth rates of the previous periods. The projected quarter-over-quarter percentage EPS growth rates are also expected to be higher than the previous periods’ growth rates.
 
EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1): The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1).
 
EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2): The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2).
 
EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3): The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3).
 
In addition to this, we have added the following parameters:
 
Current Price greater than or equal to $5: This screens out the low-priced stocks.
 
Average 20-day volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.
 
The above criteria narrowed down the universe of around 7,735 stocks to only 10. Here are the top four stocks:
 
NetEase, Inc. (NTES - Free Report) is an Internet technology company engaged in the development of applications, services and other technologies in China. The company currently has a Zacks Rank #3 (Hold). The company’s expected earnings growth rate for the current and next year is 11.6% and 24.5%, respectively. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
 
USA Truck, Inc. is engaged in the transportation of general commodity freight in interstate and foreign commerce. The company currently has a Zacks Rank #3. The company’s expected earnings growth rate for the next quarter is 148.1%.
 
AXT Inc (AXTI - Free Report) designs, develops, manufactures and distributes high-performance compound semiconductor substrates. The company currently has a Zacks Rank #3. Its expected earnings growth rate for the next quarter is 140%.
 
Moderna, Inc. (MRNA - Free Report) is a clinical-stage pharmaceutical company. The company currently has a Zacks Rank #3. Its expected earnings growth rate for the next quarter is 32.4%.
 
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
 
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
 
 
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
 
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Moderna, Inc. (MRNA) - free report >>

NetEase, Inc. (NTES) - free report >>

AXT Inc (AXTI) - free report >>

Published in